05 Jun Peg grateful for a “new age” in bladder cancer treatment
“Every minute, we’re just so grateful,” she said.
Cokins, 75, of Lake Geneva, Wis., has had no evidence of disease since her treatments in a clinical trial at UW Health | Carbone Cancer Center. The trial tested a new targeted chemotherapy approach that has since been approved by the Food and Drug Administration for standard use in bladder cancer. Cokins had such a good response that she has been off treatments since 2020.
“It’s why clinical trials are so important for patients, because it creates opportunities to bring them the most cutting-edge therapies,” said Dr. Joshua Lang, a medical oncologist specializing in genitourinary cancers who oversaw UW’s trial site. “And when we do it right, we can get these amazing, amazing benefits like what happened for Peg.” Read more…